Pro-Dex, Inc.

PDEX Healthcare Medical Instruments & Supplies

Pro-Dex, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $77.5 million, up 16.5% from fiscal 2025. In the quarter to June 2026, revenue grew 16.7%, EPS grew 143.2%, free cash flow fell 79.0% and total debt rose 43.5%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

58.26 1.76 −2.93%
Market cap
$194.1M
P/E
13.8×
Fwd P/E
23.5×
Dividend yield
—
F-score
6/9
Altman Z
7.38
Beneish M
−1.11
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
32.43% 29.83% 30.87% 30.92%

+8 more TTM periods

Piotroski F-Score
6 5 7 6
ROA
20.14% 17.24% 18.49% 18.87%
ROIC
15.75% 13.92% 17.38% 17.03%
Return on Tangible Assets
26.47% 23.72% 23.74% 23.25%
Average Days of Receivables
102.73 96.70 91.88 95.32
Free Cash Flow per Share
2.10 2.18 1.85 (0.67)
Free Cash Flow
6.76 6.97 6.02 (2.17)
Other line items

Show all line items

Columns are period end dates